California Stem Cell Report: California Stem Cell Research …

Posted: December 24, 2014 at 10:54 pm

Robert Klein, the first chairman of the California stem cell agency, is a relentless salesman for the potential of stem cell research.

The California stem cell agency is now involved in 10 clinical trials of stem cell treatments. These are very early stage trials primarily involving safety. The agency will be pushing aggressively and rapidly in the next few years for more trials. We need a home run, said Sherry Lansing, a member of the board of directors of the agency, late last year.

The agency is expected to run out of money for new grants in 2020, a date that has been revised from 2017. Future funding will depend in large part on marketable successes that resonate with future potential sources of funding, be they private or the general public via another bond issue.

Balancing speed with care and safety can be a difficult task. But a catastrophic event can squash the agencys efforts just as thoroughly as the lack of home runs.

See more here:
California Stem Cell Report: California Stem Cell Research ...

Related Posts